Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
18.81
36.84
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Relative Value
The Relative Value of one
Zhejiang Shouxiangu Pharmaceutical Co Ltd
stock under the Base Case scenario is
25.63
CNY.
Compared to the current market price of 21.53 CNY,
Zhejiang Shouxiangu Pharmaceutical Co Ltd
is
Undervalued by 16%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Zhejiang Shouxiangu Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Zhejiang Shouxiangu Pharmaceutical Co Ltd
SSE:603896
|
4.3B CNY | 6.1 | 18.6 | 19.8 | 19.8 | |
| FR |
|
L'Oreal SA
PAR:OR
|
177.8B EUR | 4.2 | 27.4 | 18.3 | 21.8 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
117.3B GBP | 2.3 | 21.2 | 177.7 | 204.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.8T INR | 9.4 | 56.4 | 38.8 | 42.3 | |
| UK |
|
HALEON PLC
LSE:HLN
|
34.2B GBP | 3 | 28.3 | 16.9 | 19.3 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
27.3B EUR | 2.8 | 37 | 15.7 | 22.5 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
26.3B USD | 1.7 | 129.4 | 12.8 | 19.5 | |
| JP |
|
Kao Corp
TSE:4452
|
3T JPY | 1.9 | 37 | 14.7 | 26.5 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.3T INR | 9 | -342.7 | 40.6 | 43.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
930.9B INR | 7.5 | 52 | 39.4 | 48.1 | |
| US |
|
Bellring Brands Inc
NYSE:BRBR
|
10.1B USD | 5.1 | 41.2 | 25.7 | 28.1 |
You don't have any saved screeners yet
